Nutrien (NYSE:NTR – Free Report) had its price target decreased by TD Securities from $64.00 to $63.00 in a research note published on Tuesday morning, BayStreet.CA reports. TD Securities currently has a buy rating on the stock.
Several other brokerages also recently commented on NTR. Hsbc Global Res downgraded Nutrien from a “hold” rating to a “moderate sell” rating in a research note on Friday, August 2nd. BMO Capital Markets reduced their target price on shares of Nutrien from $80.00 to $75.00 and set an “outperform” rating for the company in a research note on Friday, August 9th. Scotiabank dropped their price target on shares of Nutrien from $66.00 to $59.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th. UBS Group downgraded shares of Nutrien from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $66.00 to $51.00 in a research report on Thursday, October 10th. Finally, Mizuho dropped their target price on shares of Nutrien from $55.00 to $52.00 and set a “neutral” rating on the stock in a research report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, six have issued a hold rating and ten have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $60.44.
Read Our Latest Research Report on NTR
Nutrien Stock Down 0.3 %
Nutrien (NYSE:NTR – Get Free Report) last posted its quarterly earnings results on Wednesday, August 7th. The company reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.19 by $0.15. Nutrien had a return on equity of 6.91% and a net margin of 2.97%. The business had revenue of $10.16 billion for the quarter, compared to the consensus estimate of $10.82 billion. During the same period in the prior year, the business earned $2.53 EPS. The firm’s revenue for the quarter was down 12.9% on a year-over-year basis. As a group, sell-side analysts predict that Nutrien will post 3.85 EPS for the current fiscal year.
Institutional Trading of Nutrien
Institutional investors have recently added to or reduced their stakes in the stock. MQS Management LLC bought a new stake in shares of Nutrien during the third quarter valued at about $665,000. Entropy Technologies LP purchased a new position in Nutrien during the third quarter valued at approximately $265,000. Meixler Investment Management Ltd. increased its holdings in Nutrien by 4.2% during the 3rd quarter. Meixler Investment Management Ltd. now owns 7,159 shares of the company’s stock worth $344,000 after acquiring an additional 288 shares during the period. Peregrine Asset Advisers Inc. lifted its stake in Nutrien by 7.6% in the 3rd quarter. Peregrine Asset Advisers Inc. now owns 15,205 shares of the company’s stock worth $731,000 after purchasing an additional 1,080 shares in the last quarter. Finally, Tyler Stone Wealth Management boosted its holdings in Nutrien by 128.9% in the 3rd quarter. Tyler Stone Wealth Management now owns 22,170 shares of the company’s stock valued at $1,065,000 after purchasing an additional 12,485 shares during the period. Hedge funds and other institutional investors own 63.10% of the company’s stock.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Stories
- Five stocks we like better than Nutrien
- Why Are These Companies Considered Blue Chips?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Insider Buying Signals Upside for These 3 Stocks
- Financial Services Stocks Investing
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.